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DNA Double-Strand
Breaks From X-Ray–Based
Cardiac Examinations
A Randomized, Double-Blinded,
Placebo-Controlled TrialIonizing radiation can induce deoxyribonucleic acid
double-strand breaks (DSBs), which if not efﬁciently
repaired can initiate carcinogenesis. In vivo experi-
mental animal studies and in vitro human data (1)
support the case for a protective effect of anti-
oxidants against radiation-induced deoxyribonucleic
acid damage. However, clinical data in humans
are lacking. We tested in patients the hypothesis
that antioxidant pre-treatment with vitamin C or
N-acetylcysteine (NAC) may reduce DSB induction
by x-ray-based cardiac examinations.
In this single-center, double-blinded, placebo-
controlled study, we studied 29 controls who did not
undergo x-ray-based examinations (group A), 30 pa-
tients exposed to low-dose (<3 mSv) coronary com-
puted tomographic angiography (2) (group B), and
29 patients exposed to higher radiation doses (>9
mSv) in complex catheter-based cardiac interventions
(group C). The subjects, who provided written
informed consent, had an age range of 18 to 70 years.
Smoking, leukemia or lymphoma, radio- or chemo-
therapy, and radiation-based examinations within the
past 3 days were exclusion criteria. Because concerns
about increased DSBs also have been raised for expo-
sure to nonionizing radiation, such as that produced by
cardiac magnetic resonance or ultrasound imaging
(3,4), we only included controls who did not undergo
any such examination to avoid potential confounders.
The study protocol was approved by the local institu-
tional review board (KEK-2010-0352) and the Swiss
authorities (Swissmedic-2012DR2031) and was regis-
tered at ClinicalTrials.gov (NCT01578395).
Peripheral blood lymphocyte DSBs were measured
by immunoﬂuorescence as previously reported (3)
before the randomized intravenous infusion (saline
vs. 1.2 g NAC vs. 3 g vitamin C) and repeated within
minutes after the end of the x-ray-based examination(groups B and C) or without x-ray exposure (group A).
An increase in median DSB values is expressed as
excess foci, either per cell for immunoﬂuorescence
microscopy or in relative units for ﬂow cytometry
(ﬂuorescence-activated cell sorting units).
For continuous data evaluation, the Kruskal-Wallis
and Mann-Whitney U tests were applied. Chi-square
and Fisher exact tests were used for categorical var-
iables. Values of p < 0.05 were considered statisti-
cally signiﬁcant.
The median effective radiation dose differed
among groups A (0 mSv; interquartile range: 0 to
0 mSv), B (2.0 mSv; interquartile range: 1.4 to 2.4
mSv), and C (29.0 mSv; interquartile range: 15.5
to 52.6 mSv), consistent with the study design.
Although in our high-radiation group, irradiation was
fractionated during angiography, whereby consider-
able damage repair may take place, we found sub-
stantially higher DSB induction after high-dose
exposure compared with low-dose exposure by cor-
onary computed tomography angiography. In group
A, antioxidants had no impact on DSBs, with negli-
gible excess foci not differing (p ¼ NS) between
placebo (0.0), NAC (0.02), and vitamin C (0.01).
Low x-ray radiation (group B) induced 0.15 excess
foci with placebo and 0.07 (p ¼ NS) after antioxidant
pre-treatment (NAC or vitamin C). In the high–
radiation exposure group (C), antioxidant pre-
treatment yielded a signiﬁcant reduction (66%) in
excess foci compared with placebo (0.1 vs. 0.3,
p < 0.05) (Fig. 1), whereby the effect of vitamin C
(87%) was more pronounced than the effect of NAC
(43%) (p ¼ 0.005 vs. vitamin C).
Pre-treatment with antioxidants before exposure
to high radiation dose reduced the amount of excess
foci by two-thirds, ranging well within the values of
50% to 87% observed for protective effects of NAC
and vitamin C in experimental animal and cell culture
studies (1,5).
One must be prudent in extrapolating the results of
our acute-effect study with one cell type to potential
long-term effects and other cell types. Therefore, a
ﬁrm conclusion regarding the reduction of carcino-
genic risk by antioxidant pre-treatment may not be
offered, and further evaluation in larger trials should
be encouraged. However, in the context of the linear-
no-threshold theory and in view of the fact that
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FIGURE 1 Antioxidants Prevent X-Ray-Induced Double-Strand Breaks
Pre-treatment with antioxidants before high radiation exposure (>9 mSv)
reduced x-ray-induced deoxyribonucleic acid damage (excess foci).
FACS ¼ ﬂuorescence-activated cell sorting.
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118DSBs are considered the most important genetic le-
sions because they can trigger deoxyribonucleic acid
instability and exert tumorigenic effects, it seems
reasonable to deduce that the observed substantial
reduction of DSBs in lymphocytes by about two-thirds
may translate into a reduction of carcinogenic risk.
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